Rawal N, Langford R M
Orebro University Hospital, Department of Anaesthesiology and Intensive Care, Orebro, Sweden.
Eur J Anaesthesiol. 2007 Apr;24(4):299-308. doi: 10.1017/S026502150600189X. Epub 2006 Dec 8.
Survey results continue to reveal that postoperative pain is insufficiently managed throughout Europe and the rest of the world. However, the efficient use of existing resources, as well as the introduction of novel technologies, may aid in its improvement. Use of an acute pain service has the potential to improve pain management through specialized patient care and utilization of effective analgesic techniques. Multimodal analgesic techniques, which include adjuvant non-opioids and/or regional analgesic techniques, can provide effective analgesia and reduce the amount of systemic opioids (or obviate the need) for postoperative pain management. Patient-controlled analgesia modalities may also offer improvements to pain management, as in practice they provide pain relief superior to the intermittent administration of bolus doses of opioids. A novel patient-controlled analgesia modality that has been approved by the European Medicines Evaluation Agency (EMEA) for the treatment of acute, moderate-to-severe pain is the needle-free, pre-programmed fentanyl HCl iontophoretic transdermal system. This system was shown in a recent US clinical trial to be comparable in efficacy to a standard regimen of morphine intravenous patient-controlled analgesia. Adverse events associated with the use of the fentanyl iontophoretic transdermal system are generally similar to those experienced by patients using intravenous morphine patient-controlled analgesia. Considerations regarding the selection of patients for treatment with the fentanyl iontophoretic transdermal system are similar to those with other patient-controlled analgesia modalities; sufficient upper limb mobility and alertness are required to operate the system. Utilization of the fentanyl iontophoretic transdermal system, together with the guidance of an effective acute pain service, may lead to improvements in postoperative pain management.
调查结果不断显示,在欧洲及世界其他地区,术后疼痛管理仍不到位。然而,有效利用现有资源以及引入新技术,可能有助于改善这一状况。设立急性疼痛服务机构,通过专业的患者护理和有效镇痛技术的应用,有潜力改善疼痛管理。多模式镇痛技术,包括辅助性非阿片类药物和/或区域镇痛技术,可提供有效的镇痛效果,并减少术后疼痛管理中全身性阿片类药物的用量(或避免使用)。患者自控镇痛模式也可能改善疼痛管理,因为在实际应用中,它们提供的疼痛缓解效果优于间歇性推注阿片类药物。一种已获欧洲药品评估局(EMEA)批准用于治疗急性中重度疼痛的新型患者自控镇痛模式,是无针、预编程的盐酸芬太尼离子电渗透皮系统。在最近一项美国临床试验中,该系统的疗效被证明与吗啡静脉注射患者自控镇痛的标准方案相当。与使用芬太尼离子电渗透皮系统相关的不良事件通常与使用静脉注射吗啡患者自控镇痛的患者所经历的相似。关于选择使用芬太尼离子电渗透皮系统进行治疗的患者的考虑因素,与其他患者自控镇痛模式相似;操作该系统需要足够的上肢活动能力和警觉性。在有效的急性疼痛服务机构的指导下,使用芬太尼离子电渗透皮系统可能会改善术后疼痛管理。